SNAI1

protein-coding

snail family transcriptional repressor 1, the group of SNAG transcriptional repressors|Zinc fingers C2H2-type

Gene summary

The Drosophila embryonic protein snail is a zinc finger transcriptional repressor which downregulates the expression of ectodermal genes within the mesoderm. The nuclear protein encoded by this gene is structurally similar to the Drosophila snail protein, and is also thought to be critical for mesoderm formation in the developing embryo. At least two variants of a similar processed pseudogene have been found on chromosome 2. [provided by RefSeq, Jul 2008]

MANE transcript

NM_005985.4

Inheritance

AD

ClinVar variants

U:22B:1

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.26

Max pathogenic AF

—

Genomic locus

chr20:49,982,980-49,988,886

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~5.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0005453

Submitter: ClinGen

*SNAI1* was first reported in relation to autosomal dominant congenital heart disease in 2018 (Shi et al., PMID: 30448225). 2 variants (missense) that have been reported in 2 probands in 2 publications (PMIDs: 30448225, 32368696) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (expression-level data; PMID: 28880281). Expression-level data in chick and mouse embryos shows expression in the posterior heart poles and left and right sinus horns. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 10/01/24 (SOP Version 11).

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SNAI1 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 21
not providedTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005985.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
0
missense
22
clinvar
1
clinvar
23
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00220123
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 3 of 3 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005985.4RefSeqNP_005976.23MANE Select
ENST00000244050.3EnsemblENSP00000244050.23MANE Select
ENST00001085529.1EnsemblENSP00000755335.12Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
snai1aDanio rerio

Structure: postcranial axial skeleton

Quality: ossified

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Adherens junction - Homo sapiens (human)
  • Neural Crest Differentiation
  • Mesodermal Commitment Pathway
  • Kit receptor signaling pathway
  • TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • osteoblast differentiation
  • mesoderm formation
  • epithelial to mesenchymal transition
  • aortic valve morphogenesis

Molecular Function

  • RNA polymerase II regulatory region sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription repressor activity, RNA polymerase II-specific
  • protein binding
  • kinase binding

Cellular Component

  • nucleus
  • nucleoplasm
  • pericentric heterochromatin
  • cytoplasm
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000244050
Coding exons
3
Length
5888
Individuals with no LoFs
125737
Homozygous LoFs
0
Heterozygous LoFs
6
Defined
125743
p
0.0000239
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.311121590.7060.000009151687
Missense (PolyPhen)2460.1030.39932591
Synonymous-0.6577871.01.100.00000423559
Loss of Function2.30311.40.2646.39e-7106

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish00.0absent
East Asian0.0000540.000054rare
Finnish00.0absent
European (Non-Finnish)0.0000270.000026rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in induction of the epithelial to mesenchymal transition (EMT), formation and maintenance of embryonic mesoderm, growth arrest, survival and cell migration. Binds to 3 E-boxes of the E-cadherin/CDH1 gene promoter and to the promoters of CLDN7 and KRT8 and, in association with histone demethylase KDM1A which it recruits to the promoters, causes a decrease in dimethylated H3K4 levels and represses transcription. During EMT, involved with LOXL2 in negatively regulating pericentromeric heterochromatin transcription (By similarity). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (By similarity). Associates with EGR1 and SP1 to mediate tetradecanoyl phorbol acetate (TPA)-induced up- regulation of CDKN2B, possibly by binding to the CDKN2B promoter region 5'-TCACA-3. In addition, may also activate the CDKN2B promoter by itself. {ECO:0000250|UniProtKB:Q02085, ECO:0000269|PubMed:10655587, ECO:0000269|PubMed:15647282, ECO:0000269|PubMed:16096638, ECO:0000269|PubMed:20121949, ECO:0000269|PubMed:20562920, ECO:0000269|PubMed:21952048}.;

Recessive Scores

pRec
0.331

Intolerance Scores

LoFtool
0.232
RVIS EVS
0.08
RVIS percentile EVS
60.09

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.959

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.